Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 18 July

Grady Wulff
July 18, 2023

Morning Bell 17 July

Grady Wulff
July 17, 2023

Weekly Wrap 14 July

Grady Wulff
July 14, 2023

Morning Bell 14 July

Sophia Mavridis
July 14, 2023

Morning Bell 13 July

Grady Wulff
July 13, 2023

Morning Bell 12 July

Grady Wulff
July 12, 2023

Morning Bell 11 July

Sophia Mavridis
July 11, 2023

Morning Bell 10 July

Grady Wulff
July 10, 2023

Weekly Wrap 7 July

Grady Wulff
July 7, 2023

Morning Bell 7 July

Sophia Mavridis
July 7, 2023

Morning Bell 6 July

Grady Wulff
July 6, 2023

Morning Bell 5 July

Grady Wulff
July 5, 2023